Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

ClinicalTrials.gov ID: NCT07484217

Public ClinicalTrials.gov record NCT07484217. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 11:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Double-blind, Placebo-controlled, Randomized Withdrawal Study of Solriamfetol in Subjects With Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

CLARITY (Clinical Assessment of Response in the Treatment of Depression with Daytime Sleepiness Using Solriamfetol) is a Phase 3, double-blind, placebo-controlled, multicenter randomized withdrawal trial in patients with major depressive disorder (MDD) with excessive daytime sleepiness (EDS) symptoms consisting of an open-label solriamfetol treatment period and a randomized, double-blind treatment period.

Study identification

NCT ID
NCT07484217
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Axsome Therapeutics, Inc.
Industry
Enrollment
508 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 23, 2026 (Actual)
Primary completion
Dec 2028 (Estimated)
Completion
Dec 2028 (Estimated)
Last update posted
Oct 13, 2026

2026 – 2028

United States locations

U.S. sites
40
U.S. states
15
U.S. cities
36
Facility City State ZIP Site status
Clinical Research Site Tucson Arizona 85704 Recruiting
Clinical Research Site Bellflower California 90706 Recruiting
Clinical Research Site Chino California 91710 Recruiting
Clinical Research Site Glendale California 91206 Recruiting
Clinical Research Site Imperial California 92251 Recruiting
Clinical Research Site Los Angeles California 90015 Recruiting
Clinical Research Site Oceanside California 92056 Recruiting
Clinical Research Site Redlands California 92374 Recruiting
Clinical Research Site San Diego California 92123 Recruiting
Clinical Research Site Sherman Oaks California 91403 Recruiting
Clinical Research Site Walnut Creek California 94596 Recruiting
Clinical Research Site Jacksonville Florida 32256 Recruiting
Clinical Research Site Miami Florida 33122 Recruiting
Clinical Research Site Miami Florida 33176 Recruiting
Clinical Research Site Atlanta Georgia 30331 Recruiting
Clinical Research Site Norcross Georgia 30092 Recruiting
Clinical Research Site Snellville Georgia 30078 Recruiting
Clinical Research Site Chicago Illinois 60634 Recruiting
Clinical Research Site Pikesville Maryland 21208 Recruiting
Clinical Research Site Springfield Massachusetts 01103 Recruiting
Clinical Research Site Las Vegas Nevada 89102 Recruiting
Clinical Research Site Las Vegas Nevada 89119 Recruiting
Clinical Research Site Cherry Hill New Jersey 08002 Recruiting
Clinical Research Site Toms River New Jersey 08755 Recruiting
Clinical Research Site Brooklyn New York 11235 Recruiting
Clinical Research Site New York New York 10036 Recruiting
Clinical Research Site New York New York 10128 Recruiting
Clinical Research Site Staten Island New York 10314 Recruiting
Clinical Research Site The Bronx New York 10464 Recruiting
Clinical Research Site Cincinnati Ohio 45215 Recruiting
Clinical Research Site Cincinnati Ohio 45245 Recruiting
Clinical Research Site Edmond Oklahoma 73013 Recruiting
Clinical Research Site Oklahoma City Oklahoma 73116 Recruiting
Clinical Research Site Portland Oregon 97210 Recruiting
Clinical Research Site Memphis Tennessee 38119 Recruiting
Clinical Research Site Austin Texas 78759 Recruiting
Clinical Research Site Bellaire Texas 77401 Recruiting
Clinical Research Site Dallas Texas 75243 Recruiting
Clinical Research Site Houston Texas 77007 Recruiting
Clinical Research Site San Antonio Texas 78240 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07484217, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 13, 2026 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07484217 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →